Liste des publications


1.         Mouton-Liger F, Paquet C, Dumurgier J, et al. Increased cerebrospinal fluid levels of dsRNA-dependant protein kinase in Alzheimer‘s disease. Biological psychiatry 2012.

2.         Taga M, Mouton-Liger F, Paquet C, Hugon J. Modulation of oxidative stress and tau phosphorylation by the mTOR activator phosphatidic acid in SH-SY5Y cells. FEBS Lett 2011;585:1801-1806.

3.         Dumurgier J, Paquet C, Peoc'h K, et al. CSF Abeta1-42 Levels and Glucose Metabolism in Alzheimer's Disease. J Alzheimers Dis 2011.

4.         Hugon J. Rethinking Alzheimer's diseases. Rev Prat 2011;61:918-919.

5.         Arnaud N, Dabo S, Akazawa D, et al. Hepatitis C virus reveals a novel early control in acute immune response. PLoS Pathog 2011;7:e1002289.

6.         Dumurgier J, Paquet C, Benisty S, et al. Inverse association between CSF Abeta 42 levels and years of education in mild form of Alzheimer's disease: the cognitive reserve theory. Neurobiol Dis 2010;40:456-459.

7.         Dumurgier J, Elbaz A, Dufouil C, Tavernier B, Tzourio C. Hypertension and lower walking speed in the elderly: the Three-City study. J Hypertens 2010;28:1506-1514.

8.         Bose A, Mouton-Liger F, Paquet C, et al. Modulation of tau phosphorylation by the kinase PKR: implications in Alzheimer's disease. Brain Pathol 2010;21:189-200.

9.         Paquet C, Jouvent E, Mine M, et al. A cortical form of CADASIL with cerebral Abeta amyloidosis. Acta Neuropathol 2010;120:813-820.

10.       Paquet C, Mouton-Liger F, Meurs EF, et al. The PKR activator PACT is induced by Abeta. Involvement in Alzheimer's disease. Brain Pathol 2010.

11.       Dumurgier J, Elbaz A, Ducimetiere P, Tavernier B, Alperovitch A, Tzourio C. Slow walking speed and cardiovascular death in well functioning older adults: prospective cohort study. Bmj 2009;339:b4460.

12.       Paquet C, Bose A, Polivka M, et al. Neuronal phosphorylated RNA-dependent protein kinase in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 2009;68:190-198.

13.       Hugon J, Paquet C, Chang RC. Could PKR inhibition modulate human neurodegeneration? Expert Rev Neurother 2009;9:1455-1457.

14.       Damjanac M, Page G, Ragot S, et al. PKR, a cognitive decline biomarker, can regulate translation via two consecutive molecular targets p53 and Redd1 in lymphocytes of AD patients. J Cell Mol Med 2009;13:1823-1832.

15.       Pei JJ, Hugon J. mTOR-dependent signalling in Alzheimer's disease. J Cell Mol Med 2008;12:2525-2532.

16.       Hugon J, Paquet C. Targeting miRNAs in Alzheimer's disease. Expert Rev Neurother 2008;8:1615-1616.

17.       Paquet C, Hugon J. Could non coding RNA be involved in Alzheimer's disease? Med Hypotheses 2007;69:464-465.

18.       Paquet C, Boissonnot M, Roger F, Dighiero P, Gil R, Hugon J. Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 2007;420:97-99.

19.       Hugon J, Paquet C. [Molecular and therapeutic approaches of the Alzheimer's disease]. Morphologie 2007;91:221-225.